Position in BHC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
8 quarters on record
Derivatives in BHC
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$394,400
PutShares
80,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Crawford Fund Management, LLC holds $13,279,017 across 2 Drug Manufacturers - Specialty & Generic names.
All Filings in BHC
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $394,400 | 80,000 | Put | Sole | 2026-08-14 | |
| 2026-03-31 | $486,000 | 90,000 | Put | Sole | 2026-05-15 | |
| 2025-12-31 | $1,379,575 | 198,500 | Put | Sole | 2026-02-17 | |
| 2025-09-30 | $1,741,500 | 270,000 | Put | Sole | 2025-11-14 | |
| 2025-06-30 | $1,674,990 | 251,500 | Put | Sole | 2025-08-14 | |
| 2025-03-31 | $2,274,205 | 351,500 | Put | Sole | 2025-05-15 | |
| 2024-12-31 | $2,784,730 | 345,500 | Put | Sole | 2025-02-14 | |
| 2024-09-30 | $1,146,480 | 140,500 | Put | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||